This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression.

Alan F. Schatzberg, MD; Mark A. Demitrack, MD; John P. O†Reardon, MD; Elliott Richelson, MD; and Michael E. Thase, MD

Published: February 15, 2007

Article Abstract

Click to enlarge page

Major depression is a common disorder and substantial cause of disease burden worldwide. Nearly 60% of patients with depression may not achieve adequate response following antidepressant treatment. New somatic treatments that are less invasive than electroconvulsive therapy (ECT), such as transcranial magnetic stimulation (TMS), are being added to the repertoire of treatments that have the potential to be effective in depression that is resistant to pharmacologic therapies.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 68

Quick Links: